StonvexLoading…
StonvexStonvexStonvexCore line items from RNTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-5.23M | $-50.63M | $-17.97M | $-12.48M |
Net Income | $-5.84M | $-49.87M | $-17.90M | $-6.82M |
EPS (Diluted) | $-0.19 | $-1.96 | $-0.74 | $-0.53 |
Total Assets | $26.29M | $24.16M | $53.71M | $57.48M |
Total Liabilities | $14.70M | $7.24M | $7.52M | $9.47M |
Cash & Equivalents | $4.45M | $3.21M | $4.05M | $5.72M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 28.04M | 27.55M | 25.14M | 23.05M |